Skip to content

Interest Income at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1.89M-31.0%
AlTi Global, Inc. logo
AlTi Global, Inc.ALTI
-$325.25K
Moderna logo
ModernaMRNA
$72M-20.0%
ACV Auctions Inc. logo
ACV Auctions Inc.ACVA
$1.69M-10.3%
Microvast Holdings, Inc. logo
Microvast Holdings, Inc.MVST
$382K+116%
Regal Rexnord logo
Regal RexnordRRX
$4.6M+9.5%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept derm:InterestIncome.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's interest income?
Journey Medical Corporation (DERM) reported interest income of $157K in Q1 2026.
How has Journey Medical Corporation's interest income changed year-over-year?
Journey Medical Corporation's interest income increased by 5.4% year-over-year, from $149K to $157K.
What is the long-term trend for Journey Medical Corporation's interest income?
Over 4 years (2021 to 2025), Journey Medical Corporation's interest income has grown at a 314.3% compound annual growth rate (CAGR), from $2K to $589K.
What does interest income mean?
This metric represents the interest earned on cash balances, short-term investments, and other interest-bearing assets held by the company. It reflects the yield generated from the company's liquid capital reserves. While not a core driver of pharmaceutical revenue, it provides a secondary source of non-operating income that contributes to the company's overall liquidity position.